Humacyte Inc.-CW27HUMAWPreferred / convertible
13F holders, Q4 2025 (December 31)8holders +2
2new positions
0sold out
$0.09avg. 13F price*
At the end of Q4 2025, 8 institutions reported holding Humacyte Inc.-CW27 (HUMAW) in their 13F filings, up 2 from Q3 2025. 2 opened new positions and 0 sold out. The largest holders were LPL Financial LLC ($24K), Susquehanna International Group, LLP ($6K) and Sio Capital Management, LLC ($5K).
- Company
- Humacyte Inc.-CW27
- CUSIP
- 44486Q111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $11K |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 121,541 shares bought and 13,716 shares sold, net +107,825 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| LPL Financial LLC | — | No change | 259,115 | $24K |
| Susquehanna International Group, LLP | — | New | 75,376 | $6K |
| Sio Capital Management, LLC | — | No change | 49,998 | $5K |
| Jane Street Group, LLC | — | Reduce -0.9% | 49,800 | $5K |
| Two Sigma Securities, LLC | — | New | 45,342 | $4K |
| Wolverine Asset Management LLC | — | Reduce -26.3% | 36,860 | $3K |
| Toronto Dominion Bank | — | Reduce -0.5% | 20,418 | $2K |
| UBS Group AG | — | Add +1159.2% | 894 | $84 |
"% of holder's portfolio" is HUMAW's weight in each manager's 13F, not the share of Humacyte Inc.-CW27 the manager owns.